Evidence map›Paper›PMID 40210462›Full record

Trial reportGut2025

Choice of colon capsule or colonoscopy versus default colonoscopy in FIT positive patients in the Danish screening programme: a parallel group randomised controlled trial.

Gunnar Baatrup, Thomas Bjørsum-Meyer, Lasse Kaalby, Benedicte Schelde-Olesen, Morten Kobaek-Larsen, Anastasios Koulaouzidis, Rasmus Kroijer, Issam Al-Najami, Niels Buch, Anders Høgh and 4 more

Registry-linked trialAbstract readRandomized Controlled TrialComparative Study
In one paragraph

Trial report in Gut, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04049357 (Colon Capsule Endoscopy in Bowel Cancer Screening. A Randomized Controlled Trial), which is not on this map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04049357 nacompletednot on this map

Colon Capsule Endoscopy in Bowel Cancer Screening. A Randomized Controlled Trial

TypeinterventionalSponsorOdense University HospitalRan2020 to 2024Enrolled2,031ConditionsColorectal Cancer, AdenomaArmsCamera Capsule Endoscopy/ PillCam
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Gunnar BaatrupDepartment of Surgery, Odense University Hospital, Odense, Denmark.
Thomas Bjørsum-MeyerDepartment of Surgery, Odense University Hospital, Odense, Denmark.ORCID http://orcid.org/0000-0001-5253-0802
Lasse KaalbyDepartment of Surgery, Odense University Hospital, Odense, Denmark.
Benedicte Schelde-OlesenDepartment of Surgery, Odense University Hospital, Odense, Denmark.
Morten Kobaek-LarsenDepartment of Surgery, Odense University Hospital, Odense, Denmark.
Anastasios KoulaouzidisDepartment of Surgery, Odense University Hospital, Odense, Denmark.
Rasmus KroijerDepartment of Surgery, Esbjerg and Grindsted Hospital, University Hospital of Southern Denmark, Esbjerg, Denmark.ORCID http://orcid.org/0000-0003-4358-7916
Issam Al-NajamiDepartment of Surgery, Odense University Hospital, Odense, Denmark.
Niels BuchDepartment of Surgery, Odense University Hospital, Odense, Denmark.
Anders HøghDepartment of Surgery, Odense University Hospital, Odense, Denmark.
Niels QvistDepartment of Surgery, Odense University Hospital, Odense, Denmark.
Marianne Kirstine ThygesenDepartment of Surgery, Odense University Hospital, Odense, Denmark.
Ulrik DedingDepartment of Surgery, Odense University Hospital, Odense, Denmark ulrik.deding@rsyd.dk.ORCID http://orcid.org/0000-0002-8263-2989
CareForColon2015 study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundColonoscopy is among the standard tests for colorectal cancer (CRC) screening. However, uptake varies, and alternatives such as colon capsule endoscopy (CCE) are available. The uptake and detection rate of clinically significant neoplasia with CCE, compared with colonoscopy, remain unclear in this setting.

objectiveThe primary objective of this study was to compare the detection rates of advanced neoplasia between CCE and colonoscopy, using a pathway in which the study group could choose between the two procedures, while the control group was offered only colonoscopy.

designA randomised, intention-to-treat trial was conducted among Danish CRC screening participants who tested positive with a faecal immunochemical test (FIT). The trial compared the detection rate of advanced neoplasia (primary outcome) and the uptake rate of both approaches between the two arms.

resultsA total of 473 684 invitations were sent to 396 676 individuals, with 62.6% returning the test. Among them, 11 075 tests were positive (4.5%), with no significant differences between the two study groups. Among FIT-positive cases, the uptake for colonoscopy was 91.1% in the control arm and 91.7% in the study arm, where participants had a choice of methods. In the study arm, 45.8% preferred CCE, 11.4% preferred colonoscopy and 42.8% had no preference and underwent colonoscopy. Ultimately, 69.9% of patients who initially opted for CCE were later referred for colonoscopy. The rate of advanced neoplasia detection was similar between the groups: 0.67% in the study arm versus 0.64% in the control arm.

conclusionOffering CCE as an alternative to colonoscopy did not significantly alter the detection rate of advanced neoplasia, nor did it increase uptake in a screening programme with high adherence to colonoscopy following a positive FIT test. Instead, it led to a very high rate of secondary colonoscopies. Therefore, CCE cannot be recommended in this setting. TRIAL REGISTRATION NUMBER: NCT04049357 (ClinicalTrials.gov).

Indexed as

Capsule EndoscopyColonoscopyColorectal NeoplasmsEarly Detection of CancerAgedDenmarkFemaleHumansMaleMass ScreeningMiddle AgedOccult BloodPatient Acceptance of Health CareCOLORECTAL ADENOMASCOLORECTAL CANCERDIAGNOSTIC AND THERAPEUTIC ENDOSCOPYSCREENING

Identifiers

PMID40210462
PMCPMC12505048

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.